Cargando…

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis

BACKGROUND: Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and improve population risk stratification, we aimed to id...

Descripción completa

Detalles Bibliográficos
Autores principales: Santaolalla, Aida, Garmo, Hans, Grigoriadis, Anita, Ghuman, Sundeep, Hammar, Niklas, Jungner, Ingmar, Walldius, Göran, Lambe, Mats, Holmberg, Lars, Van Hemelrijck, Mieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651931/
https://www.ncbi.nlm.nih.gov/pubmed/31337337
http://dx.doi.org/10.1186/s12860-019-0210-7
_version_ 1783438459143192576
author Santaolalla, Aida
Garmo, Hans
Grigoriadis, Anita
Ghuman, Sundeep
Hammar, Niklas
Jungner, Ingmar
Walldius, Göran
Lambe, Mats
Holmberg, Lars
Van Hemelrijck, Mieke
author_facet Santaolalla, Aida
Garmo, Hans
Grigoriadis, Anita
Ghuman, Sundeep
Hammar, Niklas
Jungner, Ingmar
Walldius, Göran
Lambe, Mats
Holmberg, Lars
Van Hemelrijck, Mieke
author_sort Santaolalla, Aida
collection PubMed
description BACKGROUND: Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and improve population risk stratification, we aimed to identify metabolic profiles linked to carcinogenesis and mortality and their intrinsic associations by characterizing subgroups of individuals based on serum biomarker measurements. We included 13,615 participants from the Swedish Apolipoprotein MOrtality RISk Study who had measurements for 19 biomarkers representative of central metabolic pathways. Latent Class Analysis (LCA) was applied to characterise individuals based on their biomarker values (according to medical cut-offs), which were then examined as predictors of cancer and death using multivariable Cox proportional hazards models. RESULTS: LCA identified four metabolic profiles within the population: (1) normal values for all markers (63% of population); (2) abnormal values for lipids (22%); (3) abnormal values for liver functioning (9%); (4) abnormal values for iron and inflammation metabolism (6%). All metabolic profiles (classes 2–4) increased risk of cancer and mortality, compared to class 1 (e.g. HR for overall death was 1.26 (95% CI: 1.16–1.37), 1.67 (95% CI: 1.47–1.90), and 1.21 (95% CI: 1.05–1.41) for class 2, 3, and 4, respectively). CONCLUSION: We present an innovative approach to risk stratify a well-defined population based on LCA metabolic-defined subgroups for cancer and mortality. Our results indicate that standard of care baseline serum markers, when assembled into meaningful metabolic profiles, could help assess long term risk of disease and provide insight in disease susceptibility and etiology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12860-019-0210-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6651931
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66519312019-07-31 Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis Santaolalla, Aida Garmo, Hans Grigoriadis, Anita Ghuman, Sundeep Hammar, Niklas Jungner, Ingmar Walldius, Göran Lambe, Mats Holmberg, Lars Van Hemelrijck, Mieke BMC Mol Cell Biol Research Article BACKGROUND: Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and improve population risk stratification, we aimed to identify metabolic profiles linked to carcinogenesis and mortality and their intrinsic associations by characterizing subgroups of individuals based on serum biomarker measurements. We included 13,615 participants from the Swedish Apolipoprotein MOrtality RISk Study who had measurements for 19 biomarkers representative of central metabolic pathways. Latent Class Analysis (LCA) was applied to characterise individuals based on their biomarker values (according to medical cut-offs), which were then examined as predictors of cancer and death using multivariable Cox proportional hazards models. RESULTS: LCA identified four metabolic profiles within the population: (1) normal values for all markers (63% of population); (2) abnormal values for lipids (22%); (3) abnormal values for liver functioning (9%); (4) abnormal values for iron and inflammation metabolism (6%). All metabolic profiles (classes 2–4) increased risk of cancer and mortality, compared to class 1 (e.g. HR for overall death was 1.26 (95% CI: 1.16–1.37), 1.67 (95% CI: 1.47–1.90), and 1.21 (95% CI: 1.05–1.41) for class 2, 3, and 4, respectively). CONCLUSION: We present an innovative approach to risk stratify a well-defined population based on LCA metabolic-defined subgroups for cancer and mortality. Our results indicate that standard of care baseline serum markers, when assembled into meaningful metabolic profiles, could help assess long term risk of disease and provide insight in disease susceptibility and etiology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12860-019-0210-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-23 /pmc/articles/PMC6651931/ /pubmed/31337337 http://dx.doi.org/10.1186/s12860-019-0210-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Santaolalla, Aida
Garmo, Hans
Grigoriadis, Anita
Ghuman, Sundeep
Hammar, Niklas
Jungner, Ingmar
Walldius, Göran
Lambe, Mats
Holmberg, Lars
Van Hemelrijck, Mieke
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
title Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
title_full Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
title_fullStr Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
title_full_unstemmed Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
title_short Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
title_sort metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651931/
https://www.ncbi.nlm.nih.gov/pubmed/31337337
http://dx.doi.org/10.1186/s12860-019-0210-7
work_keys_str_mv AT santaolallaaida metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT garmohans metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT grigoriadisanita metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT ghumansundeep metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT hammarniklas metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT jungneringmar metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT walldiusgoran metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT lambemats metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT holmberglars metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis
AT vanhemelrijckmieke metabolicprofilestopredictlongtermcancerandmortalitytheuseoflatentclassanalysis